TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,208,000 | -61.5% | 2,514,773 | +7.4% | 0.00% | – |
| Q1 2019 | $3,138,000 | +152.7% | 2,341,720 | +113.1% | 0.00% | – |
| Q4 2018 | $1,242,000 | -80.0% | 1,099,088 | -51.1% | 0.00% | – |
| Q3 2018 | $6,202,000 | -24.0% | 2,247,144 | -1.6% | 0.00% | – |
| Q2 2018 | $8,156,000 | +21.9% | 2,284,816 | +4.8% | 0.00% | – |
| Q1 2018 | $6,691,000 | -49.2% | 2,179,292 | +4.1% | 0.00% | -100.0% |
| Q4 2017 | $13,183,000 | -4.9% | 2,092,649 | +3.3% | 0.00% | 0.0% |
| Q3 2017 | $13,862,000 | +37.0% | 2,026,536 | +42.8% | 0.00% | – |
| Q2 2017 | $10,117,000 | -32.8% | 1,418,874 | -13.4% | 0.00% | -100.0% |
| Q1 2017 | $15,061,000 | +165.4% | 1,638,789 | +16.4% | 0.00% | – |
| Q4 2016 | $5,675,000 | +10.5% | 1,408,369 | +5.0% | 0.00% | – |
| Q3 2016 | $5,137,000 | -7.4% | 1,341,174 | +3.9% | 0.00% | – |
| Q2 2016 | $5,550,000 | -24.9% | 1,290,655 | -19.1% | 0.00% | – |
| Q1 2016 | $7,388,000 | -64.3% | 1,595,691 | -22.6% | 0.00% | -100.0% |
| Q4 2015 | $20,689,000 | +35.0% | 2,062,674 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $15,328,000 | -77.9% | 2,054,608 | +40.3% | 0.00% | -80.0% |
| Q2 2015 | $69,460,000 | +88.8% | 1,464,152 | +45.8% | 0.01% | +150.0% |
| Q1 2015 | $36,785,000 | +28.8% | 1,003,968 | +39.6% | 0.00% | 0.0% |
| Q4 2014 | $28,553,000 | +173.2% | 719,038 | +37.3% | 0.00% | +100.0% |
| Q3 2014 | $10,450,000 | +58.6% | 523,828 | +7.3% | 0.00% | 0.0% |
| Q2 2014 | $6,588,000 | +40.9% | 488,346 | +13.7% | 0.00% | – |
| Q1 2014 | $4,676,000 | +19.3% | 429,363 | +48.2% | 0.00% | – |
| Q4 2013 | $3,918,000 | +156.7% | 289,814 | +116.1% | 0.00% | – |
| Q3 2013 | $1,526,000 | +61.3% | 134,121 | -0.4% | 0.00% | – |
| Q2 2013 | $946,000 | – | 134,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |